170 related articles for article (PubMed ID: 19713244)
1. Drug interactions in oncology: how common are they?
Riechelmann RP; Del Giglio A
Ann Oncol; 2009 Dec; 20(12):1907-12. PubMed ID: 19713244
[TBL] [Abstract][Full Text] [Related]
2. Potential Drug-drug Interactions at a Referral Pediatric Oncology Ward in Iran: A Cross-sectional Study.
Tavousi F; Sadeghi A; Darakhshandeh A; Moghaddas A
J Pediatr Hematol Oncol; 2019 Apr; 41(3):e146-e151. PubMed ID: 30531601
[TBL] [Abstract][Full Text] [Related]
3. A systematic review on drug interactions in oncology.
Riechelmann RP; Saad ED
Cancer Invest; 2006 Nov; 24(7):704-12. PubMed ID: 17118781
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials.
Marcath LA; Coe TD; Hoylman EK; Redman BG; Hertz DL
BMC Cancer; 2018 Nov; 18(1):1155. PubMed ID: 30466416
[TBL] [Abstract][Full Text] [Related]
5. Drug-drug interactions in pediatric oncology patients.
Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376
[TBL] [Abstract][Full Text] [Related]
6. Real-world prevalence of potential drug-drug interactions involving oral antineoplastic agents: a population-based study.
Kim SH; Suh Y; Ah YM; Jun K; Lee JY
Support Care Cancer; 2020 Aug; 28(8):3617-3626. PubMed ID: 31802250
[TBL] [Abstract][Full Text] [Related]
7. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists.
Chan A; Tan SH; Wong CM; Yap KY; Ko Y
Clin Ther; 2009; 31 Pt 2():2379-86. PubMed ID: 20110047
[TBL] [Abstract][Full Text] [Related]
8. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
Toivo TM; Mikkola JA; Laine K; Airaksinen M
Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
[TBL] [Abstract][Full Text] [Related]
9. Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis.
Dechanont S; Maphanta S; Butthum B; Kongkaew C
Pharmacoepidemiol Drug Saf; 2014 May; 23(5):489-97. PubMed ID: 24616171
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study.
Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A
Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of potential drug-drug interactions in patients with castration-resistant prostate cancer treated with abiraterone acetate.
Jamani R; Lee EK; Berry SR; Saluja R; DeAngelis C; Giotis A; Emmenegger U
Eur J Clin Pharmacol; 2016 Nov; 72(11):1391-1399. PubMed ID: 27561266
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.
Gagne JJ; Maio V; Rabinowitz C
J Clin Pharm Ther; 2008 Apr; 33(2):141-51. PubMed ID: 18315779
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software.
Nightingale G; Pizzi LT; Barlow A; Barlow B; Jacisin T; McGuire M; Swartz K; Chapman A
J Geriatr Oncol; 2018 Sep; 9(5):526-533. PubMed ID: 29510896
[TBL] [Abstract][Full Text] [Related]
14. Development of a chemotherapy regimen interaction database for the mobile internet: detecting interactions with psychotropics through OncoRx-MI.
Yap KY; Chui WK; Chan A;
Inform Health Soc Care; 2011 Sep; 36(3):132-46. PubMed ID: 21848450
[TBL] [Abstract][Full Text] [Related]
15. Clinically Significant Drug-Drug Interactions Involving Medications Used for Symptom Control in Patients With Advanced Malignant Disease: A Systematic Review.
Kotlinska-Lemieszek A; Klepstad P; Haugen DF
J Pain Symptom Manage; 2019 May; 57(5):989-998.e1. PubMed ID: 30776538
[TBL] [Abstract][Full Text] [Related]
16. Electronic database to detect drug-drug interactions between antidepressants and oral anticancer drugs from a cancer center in Singapore: implications to clinicians.
Chan A; Yap KY; Koh D; Low XH; Cheung YT;
Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):939-47. PubMed ID: 21732473
[TBL] [Abstract][Full Text] [Related]
17. Drug-drug interactions in inpatient and outpatient settings in Iran: a systematic review of the literature.
Nabovati E; Vakili-Arki H; Taherzadeh Z; Hasibian MR; Abu-Hanna A; Eslami S
Daru; 2014 Jun; 22(1):52. PubMed ID: 24965959
[TBL] [Abstract][Full Text] [Related]
18. Potential drug-drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors.
Fernández de Palencia Espinosa MÁ; Díaz Carrasco MS; Alonso Romero JL; de la Rubia Nieto A; Espuny Miró A
Int J Clin Pharm; 2015 Dec; 37(6):1021-7. PubMed ID: 26391788
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity and specificity of drug interaction databases to detect interactions with recently approved oral antineoplastics.
Bossaer JB; Eskens D; Gardner A
J Oncol Pharm Pract; 2022 Jan; 28(1):82-86. PubMed ID: 33435823
[TBL] [Abstract][Full Text] [Related]
20. A pilot study on the impact of known drug-drug interactions in cancer patients.
Ussai S; Petelin R; Giordano A; Malinconico M; Cirillo D; Pentimalli F
J Exp Clin Cancer Res; 2015 Aug; 34(1):89. PubMed ID: 26303220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
